Effect of ISABel Bed 1 Ans ISABel Bed 2 Clinical Trial
— ISABelOfficial title:
ISABel: Intelligent Sleep Apnoea Bed
Verified date | February 2022 |
Source | Swiss Federal Institute of Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this trial is to assess the effect of two automated beds on severity of POSA as well as the feasibility of these beds as POSA treatment. These beds are equipped with sensors detecting apnoeas and hypopnoeas from physiological measurements - such as chest movement or breathing sound -, and coherently reacting by actively changing the user position whenever an apnoeic event occurs. Thereby we will investigate a possible treatment alternative to already established OSA therapies, either as a valuable add-on for patients eligible to the currently available therapies or as primary treatment option.
Status | Terminated |
Enrollment | 10 |
Est. completion date | January 24, 2022 |
Est. primary completion date | January 24, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Documented supine positional OSA (AHIsupine/AHInonsupine =2) with a total AHI of =10 events/hour - Age =18 years and <80 years - Written informed consent documented by signature Exclusion Criteria: - Previous or current use of positional therapy - Use of home oxygen therapy - Documented hypoventilation syndrome - Documented Cheyne-Stokes breathing - Documented moderate-to-severe or severe obstructive lung diseases - Chronic heart failure - Documented active drug or alcohol abuse - Known or suspected non-compliance - Inability to follow the procedures of the study, e.g. due to language problems, documented psychological disorders, documented dementia, etc. of the participant - Current professional driver or any either documented or reported previous sleep-related driving accidents - People working with or operating heavy machinery - Child-bearing age: female participants who are neither surgically sterilised / hysterectomised nor post-menopausal for longer than 2 years are considered as being of child bearing potential - Documented unstable, untreated coronary or peripheral artery disease, severe hypertension or hypotension (=180/110 or =90/60 mmHg) - BMI >40 kg/m2 or body weight >130 kg - Being the investigator, his/her family members, employees, or other dependent persons |
Country | Name | City | State |
---|---|---|---|
Switzerland | ETH Zurich | Zurich |
Lead Sponsor | Collaborator |
---|---|
Swiss Federal Institute of Technology | University of Zurich |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of the presence of a difference in supine AHI either in ISABel Bed 1 or ISABel Bed 2 | The primary outcome will be the presence of a difference in supine AHI (events/hour) between the control bed (polysomnography - PSG- on Day 6) and either ISABel Bed 1 or ISABel Bed 2 (respectively on Day 7 and Day 8 to 14, depending on the randomisation order). AHI supine refers to the part of the total AHI that is caused by lying in supine position. This index is per definition twice as much as the non-supine AHI in patients with POSA. The intervention should reduce the time spent in supine position and therefore reduce the supine AHI. | three nights | |
Secondary | User feasibility of ISABel Bed 1 or ISABel Bed 2 | snoring, sleep architecture | three nights | |
Secondary | User effect of ISABel Bed 1 or ISABel Bed 2 | total AHI (events/hours), ODI4%, SpO2%, total arousal index (events/hours) | three nights | |
Secondary | User tolerance | morning blood pressure and heart rate | three nights | |
Secondary | Difference ISABel Bed 1 and ISABel Bed 2 | in supine AHI between the two beds | three nights | |
Secondary | Assess reliability fo the machine learning algorithms of ISABel Bed 1 and ISABel Bed 2 | data collection | three nights | |
Secondary | Safety of ISABel Bed 1 and ISABel Bed 2 | Sleep structure and quality | three nights |